We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
Date | Time | Source | Headline |
---|---|---|---|
24/4/2024 | 09:14 | ALNC | GSK's Jemperli with chemotherapy accepted for priority review by FDA |
24/4/2024 | 07:00 | UK RNS | GSK PLC US FDA accepts new indication filing for Jemperli |
19/4/2024 | 15:30 | UK RNS | GSK PLC Director/PDMR Shareholding |
17/4/2024 | 15:30 | UK RNS | GSK PLC Director/PDMR Shareholding |
17/4/2024 | 08:46 | ALNC | TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment |
17/4/2024 | 07:05 | UK RNS | GSK PLC GSK announces additional EAGLE-1 results |
17/4/2024 | 07:00 | UK RNS | GSK PLC Results from long-term data relating to Shingrix |
16/4/2024 | 14:11 | UK RNS | GSK PLC Amendment - Director/PDMR Shareholding |
16/4/2024 | 08:59 | ALNC | GSK's latest meningitis vaccine accepted for review by US regulator |
16/4/2024 | 07:00 | UK RNS | GSK PLC FDA accepts GSK meningitis vaccine candidate file |
1 Year Gsk Chart |
Intraday Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions